SCHEMBL15800091

SCHEMBL15800091

CC(=O)CCCCCCN1CCCc2nc(-c3ccccc3)c(-c3ccccc3)nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.39
▸ PTGIR P43119 4/20 0.39
▸ HDAC1 Q13547 5/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ PAOX Q6QHF9 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CKS1B P61024 1/20 0.35
▸ SKP1 P63208 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15800096 1.00 FAAH (0.39) FAAHPTGIRHDAC1HDAC3HDAC2
SCHEMBL15800095 0.99 FAAH (0.37) FAAHPTGIRHDAC1HDAC3HDAC2
SCHEMBL363697 0.92 PTGIR (0.47) FAAHPTGIRKDM4EALDH1A1MAPT
SCHEMBL362539 0.92 PTGIR (0.47) FAAHPTGIRKDM4EALDH1A1MAPT
SCHEMBL361139 0.91 PTGIR (0.45) FAAHPTGIRKDM4EALDH1A1TDP1
SCHEMBL15800093 0.90 NPC1 (0.36) FAAHHDAC1HDAC3HDAC2HDAC8
SCHEMBL15800092 0.89 FAAH (0.40) FAAHHDAC1PAOXCYP3A4
SCHEMBL361581 0.88 LTB4R (0.44) FAAHPTGIRALDH1A1TDP1MAPT
SCHEMBL363395 0.88 LTB4R (0.44) FAAHPTGIRALDH1A1TDP1MAPT
SCHEMBL361701 0.87 FAAH (0.53) FAAHKDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754085-B2 Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist NOVARTIS AG (CH) 2014-06-17 — — US disclosed
Send feedback